Cargando…

The incidence of the novel coronavirus SARS-CoV-2 among asymptomatic patients: A systematic review

BACKGROUND: The recent outbreak of the coronavirus disease 2019 (COVID-19) has quickly spread globally since its discovery in Wuhan, China, in December 2019. A comprehensive strategy – including surveillance, diagnostics, research, and clinical treatment – is urgently needed to win the battle agains...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Sadeq, Duaa W., Nasrallah, Gheyath K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330573/ https://www.ncbi.nlm.nih.gov/pubmed/32623083 http://dx.doi.org/10.1016/j.ijid.2020.06.098

Ejemplares similares

Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2
por: Younes, Nadin, et al.
Publicado: (2020)

Performance evaluation of novel fluorescent-based lateral flow immunoassay (LFIA) for rapid detection and quantification of total anti-SARS-CoV-2 S-RBD binding antibodies in infected individuals
por: Shurrab, Farah M., et al.
Publicado: (2022)

The Spectrum of Mutations of Homocystinuria in the MENA Region
por: Al-Sadeq, Duaa W., et al.
Publicado: (2020)

Do preexisting antibodies against seasonal coronaviruses have a protective role against SARS-CoV-2 infections and impact on COVID-19 severity?
por: Nasrallah, Gheyath K.
Publicado: (2022)

Low Risk of Serological Cross-Reactivity between the Dengue Virus and SARS-CoV-2-IgG Antibodies Using Advanced Detection Assays
por: Shurrab, Farah M., et al.
Publicado: (2022)

Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies
por: Zedan, Hadeel T., et al.
Publicado: (2022)

Effect of multiple freeze–thaw cycles on the detection of anti-SARS-CoV-2 IgG antibodies
por: Shurrab, Farah M., et al.
Publicado: (2021)

Is preexisting immunity to seasonal coronaviruses limited to cross-reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France
por: Zedan, Hadeel T., et al.
Publicado: (2021)

Diagnostic Efficiency of Three Fully Automated Serology Assays and Their Correlation with a Novel Surrogate Virus Neutralization Test in Symptomatic and Asymptomatic SARS-COV-2 Individuals
por: Younes, Salma, et al.
Publicado: (2021)

Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19)
por: Al-Tawfiq, Jaffar A.
Publicado: (2020)

Neutralizing antibodies against SARS-CoV-2 are higher but decline faster in mRNA vaccinees compared to individuals with natural infection
por: Abou-Saleh, Haissam, et al.
Publicado: (2022)

Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update
por: Smatti, Maria K., et al.
Publicado: (2018)

Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence population
por: Nasrallah, Gheyath K., et al.
Publicado: (2021)

The Current Status of Cytomegalovirus (CMV) Prevalence in the MENA Region: A Systematic Review
por: Al Mana, Hassan, et al.
Publicado: (2019)

Epidemiology of SARS-CoV2 in Qatar’s primary care population aged 10 years and above
por: Syed, Mohamed Ahmed, et al.
Publicado: (2021)

Asymptomatic SARS-CoV-2 infection
por: Ooi, Eng Eong, et al.
Publicado: (2020)

Assessment of the Neutralizing Antibody Response of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Naïve and Previously Infected Individuals: A Comparative Study
por: Shurrab, Farah M., et al.
Publicado: (2022)

SARS-Coronavirus (SARS-CoV)
por: Kehm, Roland
Publicado: (2009)

Follow‐up of SARS‐CoV‐2 positive subgroup from the Asymptomatic novel CORonavirus iNFection study
por: Meyers, Kristin J., et al.
Publicado: (2021)

Limited Secondary Transmission of the Novel Coronavirus (SARS-CoV-2) by Asymptomatic and Mild COVID-19 Patients in Bhutan
por: Tshokey, Tshokey, et al.
Publicado: (2021)

Assessment of Broadly Reactive Responses in Patients With MERS-CoV Infection and SARS-CoV-2 Vaccination
por: Zedan, Hadeel T., et al.
Publicado: (2023)

Asymptomatic and presymptomatic transmission of SARS-CoV-2: A systematic review
por: Savvides, Christina, et al.
Publicado: (2020)

Systematic screening on admission for SARS-CoV-2 to detect asymptomatic infections
por: Stadler, Rahel N., et al.
Publicado: (2021)

Enhancing the sensitivity of rapid antigen detection test (RADT) of different SARS-CoV-2 variants and lineages using fluorescence-labeled antibodies and a fluorescent meter
por: Nasrallah, Gheyath K., et al.
Publicado: (2023)

An Exploration of Nanoparticle-Based Diagnostic Approaches for Coronaviruses: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Al-Hindawi, Ahmed, et al.
Publicado: (2022)

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Huh, Jung Eun, et al.
Publicado: (2021)

The relation between avian coronaviruses and SARS-CoV-2 coronavirus
por: Al-Khalaifah, Hanan, et al.
Publicado: (2022)

Potential SARS-CoV-2 infectiousness among asymptomatic healthcare workers
por: Pimenoff, Ville N., et al.
Publicado: (2021)

Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 helicase inhibitors: a systematic review of invitro studies
por: Mehyar, Nimer
Publicado: (2023)

The Coronaviruses of Animals and Birds: Their Zoonosis, Vaccines, and Models for SARS-CoV and SARS-CoV2
por: Alluwaimi, Ahmed M., et al.
Publicado: (2020)

Chloroquine for the 2019 novel coronavirus SARS-CoV-2
por: Colson, Philippe, et al.
Publicado: (2020)

Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant
por: Abu-Raddad, Laith J, et al.
Publicado: (2021)

Human herpes simplex virus-6 (HHV-6) detection and seroprevalence among Qatari nationals and immigrants residing in Qatar
por: Al-Sadeq, Duaa W., et al.
Publicado: (2021)

Validation of a Novel Fluorescent Lateral Flow Assay for Rapid Qualitative and Quantitative Assessment of Total Anti-SARS-CoV-2 S-RBD Binding Antibody Units (BAU) from Plasma or Fingerstick Whole-Blood of COVID-19 Vaccinees
por: Younes, Nadin, et al.
Publicado: (2022)

Estimating asymptomatic SARS-CoV-2 infections in a geographic area of low disease incidence
por: Caturano, Valeria, et al.
Publicado: (2021)

Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)

Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV
por: Xu, Jiabao, et al.
Publicado: (2020)

Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2
por: Meyerowitz, Eric A, et al.
Publicado: (2021)

Asymptomatic SARS-CoV-2 Carriers: A Systematic Review and Meta-Analysis
por: Syangtan, Gopiram, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_khd2pm1c3hhor02a885r5vblal